EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 117 filers reported holding EDGEWISE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $538 | -57.1% | 29,846 | -56.6% | 0.00% | -50.0% |
| Q1 2024 | $1,253 | +62.1% | 68,698 | -2.8% | 0.00% | +100.0% |
| Q4 2023 | $773 | +208.0% | 70,693 | +61.1% | 0.00% | – |
| Q3 2023 | $251 | +143.7% | 43,871 | +228.6% | 0.00% | – |
| Q2 2023 | $103 | +15.7% | 13,349 | -0.3% | 0.00% | – |
| Q1 2023 | $89 | -58.8% | 13,384 | -44.5% | 0.00% | – |
| Q4 2022 | $216 | -99.9% | 24,115 | +50.5% | 0.00% | – |
| Q3 2022 | $158,000 | +23.4% | 16,025 | 0.0% | 0.00% | – |
| Q2 2022 | $128,000 | -53.1% | 16,025 | -43.1% | 0.00% | – |
| Q1 2022 | $273,000 | -3.2% | 28,174 | +52.6% | 0.00% | – |
| Q4 2021 | $282,000 | +58.4% | 18,460 | +72.1% | 0.00% | – |
| Q3 2021 | $178,000 | -21.2% | 10,725 | +1.2% | 0.00% | – |
| Q2 2021 | $226,000 | – | 10,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $16,997,051 | 13.69% |
| Novo Holdings A/S | 6,071,703 | $66,424,431 | 4.10% |
| Orbimed Advisors | 14,567,176 | $159,364,905 | 3.18% |
| Opaleye Management Inc. | 699,000 | $7,647,060 | 2.03% |
| Frazier Life Sciences Management, L.P. | 2,667,203 | $29,179,201 | 1.56% |
| SECTORAL ASSET MANAGEMENT INC | 327,801 | $3,586,143 | 1.54% |
| Cormorant Asset Management, LP | 2,551,989 | $27,918,760 | 1.33% |
| DAFNA Capital Management LLC | 449,384 | $4,916,261 | 1.18% |
| Parkman Healthcare Partners LLC | 651,625 | $7,128,778 | 1.00% |
| EcoR1 Capital, LLC | 3,493,194 | $38,215,542 | 0.99% |